MARIANI, MARCO VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 917
EU - Europa 629
AS - Asia 322
AF - Africa 8
SA - Sud America 5
OC - Oceania 2
Totale 1.883
Nazione #
US - Stati Uniti d'America 900
IT - Italia 379
SG - Singapore 199
SE - Svezia 54
FI - Finlandia 51
IN - India 50
ID - Indonesia 29
BG - Bulgaria 28
DE - Germania 27
CN - Cina 24
CA - Canada 15
RU - Federazione Russa 15
GB - Regno Unito 11
IE - Irlanda 11
RO - Romania 9
FR - Francia 8
TG - Togo 8
UA - Ucraina 8
HK - Hong Kong 7
ES - Italia 6
NL - Olanda 6
GR - Grecia 5
TR - Turchia 5
AR - Argentina 4
MY - Malesia 3
PK - Pakistan 3
PL - Polonia 3
AU - Australia 2
BE - Belgio 2
BZ - Belize 2
IR - Iran 2
LT - Lituania 2
AL - Albania 1
CL - Cile 1
HR - Croazia 1
LV - Lettonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.883
Città #
Rome 161
Singapore 150
Fairfield 96
Chandler 95
Ashburn 75
Helsinki 47
Woodbridge 45
Houston 44
San Paolo di Civitate 42
Santa Clara 41
Wilmington 39
Seattle 34
Cambridge 30
Princeton 30
Jakarta 29
Sofia 28
Lawrence 25
Ann Arbor 24
Milan 21
San Diego 20
Millbury 18
New York 14
Boardman 12
Dallas 12
Dublin 11
Boston 8
Lomé 8
Moscow 8
Toronto 8
Bremen 7
Amsterdam 6
Dearborn 6
Madrid 6
Pune 6
Falkenstein 5
Hong Kong 5
Ottawa 5
Redwood City 5
Andover 4
Beijing 4
Bonate Sotto 4
Bühl 4
Lappeenranta 4
Norwalk 4
Paris 4
Plano 4
Straubenhardt 4
Verona 4
Viareggio 4
Caltagirone 3
Cervino 3
Federal 3
Formia 3
Fremont 3
Lariano 3
London 3
Matera 3
Melikgazi 3
Montesilvano Marina 3
Pescara 3
Phoenix 3
Athens 2
Bangalore 2
Belize City 2
Bologna 2
Brescia 2
Bristol 2
Brussels 2
Buffalo 2
Camponogara 2
Florence 2
Frankfurt am Main 2
Guardavalle 2
Guidonia Montecelio 2
Los Angeles 2
Mannheim 2
Mentana 2
Montefredane 2
Munich 2
Nanjing 2
Poggibonsi 2
Romainville 2
Rovellasca 2
Shenzhen 2
Surbo 2
Teramo 2
Trabzon 2
Vrilissia 2
West Jordan 2
Aurora 1
Baoding 1
Bari 1
Bratislava 1
Bucharest 1
Bussolengo 1
Cardito 1
Chengdu 1
Cluj-Napoca 1
Des Moines 1
Fubine 1
Totale 1.373
Nome #
Prevention of cardiovascular disease. screening for magnesium deficiency 95
Structural and myocardial dysfunction in heart failure beyond ejection fraction 86
Hospital mortality in decompensated heart failure. a pilot study 77
Triggers for atrial fibrillation. the role of anxiety 76
Correction to. structural and myocardial dysfunction in heart failure beyond ejection fraction (heart failure reviews, (2019), 10.1007/s10741-019-09828-8) 71
Advanced heart failure and end-stage heart failure. does a difference exist 71
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis 66
Cardiac and vascular remodeling after 6 months of therapy with sacubitril/valsartan. mechanistic insights from advanced echocardiographic analysis 66
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 61
Arrhythmic risk in elderly patients candidates to transcatheter aortic valve replacement. predicative role of repolarization temporal dispersion 59
Potential role of eNOS genetic variants in ischemic heart disease susceptibility and clinical presentation 52
Possible predicative role of electrical risk score on transcatheter aortic valve replacement outcomes in older patients. preliminary data 51
Ischemic heart disease and heart failure. role of coronary ion channels 51
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 51
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension 51
MULTIMODALITY IMAGING IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION DECISION MAKING IN HEART FAILURE PATIENTS: ROLE OF 123-IODINE METAIODOBENZYLGUANITIDINE IMAGING AND CARDIAC MAGNETIC RESONANCE 49
Flecainide in ventricular arrhythmias. from old myths to new perspectives 48
Myocardial ischemia in women when genetic susceptibility matters 46
Delayed efficacy of radiofrequency catheter ablation on arrhythmias originating in the interventricular basal septum 45
Current approaches to worsening heart failure. pathophysiological and molecular insights 42
The scar. the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias 41
Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy 41
Clinical, procedural and lead outcomes associated with different pacing techniques. a network meta-analysis 39
Rivaroxaban in atrial fibrillation cardioversion: an update 39
Electrocardiographic features, mapping and ablation of idiopathic outflow tract ventricular arrhythmias 39
Sporadic high pacing and shock impedance on remote monitoring in hybrid implantable cardioverter-defibrillator systems: clinical impact and management 37
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation 37
Left atrial appendage exclusion in atrial fibrillation radiofrequency ablation during mitral valve surgery: a single-center experience 35
Telehealth. a winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension 35
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 32
Futility in cardiology. the need for a change in perspectives 31
Impact of COVID-19 pandemic on cardiac electronic device management and role of remote monitoring 31
Spontaneous coronary artery dissection in clinical practice. pathophysiology and therapeutic approaches 28
The feasibility, effectiveness and acceptance of virtual visits as compared to in-person visits among clinical electrophysiology patients during the covid-19 pandemic 27
Reply to the editor-high subthreshold pacing impedance from device-lead connection issues 27
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy. results from a single center experience 24
Incidence and determinants of spontaneous cardioversion of early onset symptomatic atrial fibrillation 24
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias 23
Biobanks: the unmet need in heart failure management 22
Cardiac contractility modulation. from molecular patterns to tailored treatment in heart failure subgroups 20
Catheter Ablation For Papillary Muscle Arrhythmias A Systematic Review 20
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension. a systematic review and network meta-analysis 19
Telemedicine: an effective and low-cost lesson from the covid-19 pandemic for the management of heart failure patients 17
Heart failure 'the cancer of the heart'. The prognostic role of the HLM score 17
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 17
null 15
Protection against ischemic heart disease. a joint role for eNOS and the KATP channel 13
New challenges in heart failure with reduced ejection fraction. managing worsening events 13
null 13
Prognostic assessment of hlm score in heart failure due to ischemic heart disease. a pilot study 10
Probability score to predict spontaneous conversion to sinus rhythm in patients with symptomatic atrial fibrillation when less could be more 9
Usefulness of empiric superior vena cava isolation in paroxysmal atrial fibrillation ablation. a meta-analysis of randomized clinical trials 9
Pulsed field energy in atrial fibrillation ablation. from physical principles to clinical applications 8
Case report. epi-endocardial bridges in refractory cavotricuspid isthmus-dependent atrial flutter. technical analysis of epi-endocardial breakthrough 8
Mechanical circulatory support systems in the management of ventricular arrhythmia.: a contemporary overview 8
Efficacy of modern therapies for heart failure with reduced ejection fraction in specific population subgroups. a systematic review and network meta-analysis 6
Finerenone. questions and answers-the four fundamental arguments on the new-born promising non-steroidal mineralocorticoid receptor antagonist 6
The role of high-sensitivity troponin t regarding prognosis and cardiovascular outcome across heart failure spectrum 6
Antiarrhythmic drug use in pregnancy. considerations and safety profiles 6
SGLT2i effect on atrial fibrillation. a network meta-analysis of randomized controlled trials 6
Tailored care for cardiac health. risk stratification and gentamicin-infused collagen sponges to minimize cardiac device infections and healthcare costs 5
Filling the gaps in anticoagulation management in patients with end-stage chronic kidney disease 5
Italian registry in the setting of atrial fibrillation ablation with rivaroxaban - IRIS 4
Relevance of anatomical significance of av nodal structures within koch's triangle and pyramid 4
High-density mapping of koch's triangle during sinus rhythm and typical atrioventricular nodal re-entrant tachycardia, integrated with direct recording of atrio-ventricular node structure potential 3
Totale 2.093
Categoria #
all - tutte 9.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 0 0 0 0 19 21 16 12 9 7 11
2020/2021185 10 11 1 4 17 4 5 26 32 44 15 16
2021/2022375 12 7 21 33 37 15 3 37 45 25 86 54
2022/2023442 57 98 16 41 49 38 13 34 47 14 29 6
2023/2024449 16 45 32 30 55 69 12 51 6 54 34 45
2024/2025480 30 81 55 74 145 95 0 0 0 0 0 0
Totale 2.093